Clinical Trial Update: An RCT of Oseltamivir in Outpatients With CPD: A Pilot Study. [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial of oseltamivir in outpatients with chronic pulmonary disease and influenza was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Disease

Drugs mentioned

• OSELTAMIVIR (oseltamivir phosphate)

Snippet

Sponsor: McMaster University | Conditions: Pulmonary Disease, Influenza | Phase 4 | Status: WITHDRAWN